Btk inhibitor 2

CAS: 1558036-85-3

Ref. 3D-IMC03685

Produktinformation

• Name: Btk inhibitor 2

Beschreibung

Btk inhibitor 2 is a protein kinase inhibitor that was developed to target the B-cell lymphoma tumor necrosis factor receptor. It binds to the ATP binding site of Btk and prevents activation of the kinase. This drug has been shown to be effective in treating cancer by inhibiting cancer-related genes and promoting apoptosis in cancer cells. The drug has also been shown to have an effect on skeletal muscle, with a dose-dependent response for increasing muscle mass and decreasing fat content.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 431.49 g/mol
• Formel: C₂₄H₂₅N₅O₃
• Reinheit: Min. 95%